Loading...

Tommy Sheu

Title(s)Assistant Professor of Clinical Radiation Oncology
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Pomona College, Claremont, CABA05/2007Chemistry
    Baylor College of Medicine, Houston, TXMD05/2014Medicine
    University of Texas School of Public Health, Houston, TXMPH05/2014Public Health
    University of Hawaii, John A. Burns School of Medicine, Honolulu, HI06/2015Internal Medicine-Prelim
    The University of Texas MD Anderson Cancer Center, Houston, TX06/2019Radiation Oncology

    Collapse Overview 
    Collapse Overview
    Tommy Sheu, MD, MPH is an Assistant Professor of Clinical Radiation Oncology in the Keck School of Medicine at the University of Southern California. He primarily treats patients at USC's satellite clinic located at the Fred A. Jordan Radiation Oncology Center at St. Jude Medical Center in Fullerton, CA. He joined USC's Department of Radiation Oncology in August 2019.

    Dr. Sheu graduated from Pomona College in Claremont, CA with a Bachelor of Arts in Chemistry. He received his medical degree at Baylor College of Medicine and his Master of Public Health at The University of Texas School of Public Health in Houston, TX. After completing his internship in Internal Medicine at the University of Hawaii John A. Burns School of Medicine in Honolulu, Dr. Sheu completed his residency in radiation oncology at The University of Texas MD Anderson Cancer Center in Houston, TX.

    Dr. Sheu is interested in patient-centered outcomes research and is interested in designing clinical tools to help guide clinical decisions. He has published research on cancers of the head and neck, lung, central nervous system and lymphoma. His foremost passion is providing the best, individualized care for his patients.

    Clinical Expertise: Head and Neck, CNS, Lymphoma

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting. JAMA Intern Med. 2019 03 01; 179(3):324-332. Huo J, Xu Y, Sheu T, Volk RJ, Shih YT. PMID: 30640382.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    2. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma. Value Health. 2019 Mar; 22(3):284-292. Huo J, Aloia TA, Xu Y, Chung TH, Sheu T, Tina Shih YC. PMID: 30832966.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Intensity Modulated Radiation Therapy Versus Volumetric Arc Radiation Therapy in the Treatment of Glioblastoma-Does Clinical Benefit Follow Dosimetric Advantage? Adv Radiat Oncol. 2019 Jan-Mar; 4(1):50-56. Sheu T, Briere TM, Olanrewaju AM, McAleer MF. PMID: 30706010.
      View in: PubMed   Mentions:
    4. Dosimetric advantages of stereotactic radiosurgery as a boost to adjuvant conventional radiotherapy in the setting of adenoid cystic carcinoma of the parotid with skull base invasion. Clin Case Rep. 2018 Nov; 6(11):2126-2130. Phan JL, Pollard C, Wang H, Ng SP, Sheu T, Ginsberg LE, Hessel AC, Gidley PW, Rosenthal DI, Phan J. PMID: 30455905.
      View in: PubMed   Mentions:
    5. Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy. Adv Radiat Oncol. 2018 Oct-Dec; 3(4):639-646. Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, Ahmed S, Alousi AM, Dabaja B, Pinnix CC. PMID: 30370365.
      View in: PubMed   Mentions:
    6. Incompletely treated malignancies of the major salivary gland: Toward evidence-based care. Head Neck. 2018 08; 40(8):1630-1638. Tam S, Sandulache VC, Metwalli KA, Rock CD, Eraj SA, Sheu T, El-Naggar AK, Fuller CD, Weber RS, Lai SY. PMID: 29734482.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma. Int J Radiat Oncol Biol Phys. 2018 04 01; 100(5):1146-1154. Milgrom SA, Pinnix CC, Chi TL, Vu TH, Gunther JR, Sheu T, Fowler N, Westin JR, Nastoupil LJ, Oki Y, Fayad LE, Neelapu S, Rodriguez MA, Hagemeister FB, Fanale MA, Lee HJ, Hosing C, Ahmed S, Nieto Y, Shpall EJ, Dabaja BS. PMID: 29452771.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis. Am J Clin Oncol. 2018 Jan; 41(1):46-52. Hong J, Liao Z, Zhuang Y, Levy LB, Sheu T, Heymach JV, Nguyen QN, Xu T, Komaki R, Gomez DR. PMID: 26535988.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base. Cancer. 2017 05 01; 123(9):1653-1661. Pezzi TA, Mohamed ASR, Sheu T, Blanchard P, Sandulache VC, Lai SY, Cabanillas ME, Williams MD, Pezzi CM, Lu C, Garden AS, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB. PMID: 28026871.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer. 2016 Mar 01; 138(5):1290-7. Shoultz-Henley S, Garden AS, Mohamed AS, Sheu T, Kroll MH, Rosenthal DI, Gunn GB, Hayes AJ, French C, Eichelberger H, Kalpathy-Cramer J, Smith BD, Phan J, Ayoub Z, Lai SY, Pham B, Kies M, Gold KA, Sturgis E, Fuller CD. PMID: 26414107.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):850-7. Sheu T, Heymach JV, Swisher SG, Rao G, Weinberg JS, Mehran R, McAleer MF, Liao Z, Aloia TA, Gomez DR. PMID: 25216859.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    12. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. PMID: 25104816.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    13. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):570-5. Gomez DR, Poenisch F, Pinnix CC, Sheu T, Chang JY, Memon N, Mohan R, Rozner MA, Dougherty AH. PMID: 24074931.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses. Radiother Oncol. 2013 Oct; 109(1):21-5. Sheu T, Molkentine J, Transtrum MK, Buchholz TA, Withers HR, Thames HD, Mason KA. PMID: 24060173.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    15. Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer. Radiat Oncol. 2012 Sep 11; 7:154. Brooks C, Sheu T, Bridges K, Mason K, Kuban D, Mathew P, Meyn R. PMID: 22967802.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    Tommy's Networks
    Concepts (116)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑